Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 9 2014
Print

Search Results for 'Financial Report: Alexion'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 24, 2014
Solaris revenue up 67% in the quarter Read More »
By Gil Roth
Published January 30, 2014
Soliris sales continue to climb Read More »
By Kristin Brooks
Published January 13, 2014
To develop therapeutics for rare diseases Read More »
Published April 25, 2013
Soliris continues to rise Read More »
Published February 14, 2013
Solaris sales climb 41% in the quarter Read More »
Published October 24, 2012
Revenues up 44% in the quarter Read More »
Published July 25, 2012
Revenues up 48% in the quarter Read More »
Published July 21, 2011
Soliris sales jump 48% to $185.7 million. Read More »
Solaris revenue up 67% in the quarter Read More »
SPR & Flow Cytometry For Biosimilars
By James Hulse, Ph.D. and Chris Cox, Ph.D. , EMD Millipore
Published May 6, 2013
Evaluating the pharmacodynamics of biosimilar monoclonal antibodies Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On